Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
West Pharmaceutical Services ( (WST) ) has provided an update.
On July 21, 2025, West Pharmaceutical Services announced the appointment of Robert McMahon as the new Senior Vice President & Chief Financial Officer, effective August 4, 2025. McMahon, who previously served as CFO at Agilent Technologies, brings extensive experience in finance and leadership within the healthcare industry. He will succeed Bernard Birkett, who will retire and transition to a Senior Advisor role until the end of 2025. This strategic appointment is expected to enhance West’s financial strategies and contribute to long-term shareholder value.
The most recent analyst rating on (WST) stock is a Buy with a $345.00 price target. To see the full list of analyst forecasts on West Pharmaceutical Services stock, see the WST Stock Forecast page.
Spark’s Take on WST Stock
According to Spark, TipRanks’ AI Analyst, WST is a Neutral.
West Pharmaceutical Services’ overall stock score is moderate due to strong financial performance and positive earnings guidance. However, technical indicators and valuation concerns present some risks. The financial health of the company remains robust, but challenges highlighted in the earnings call and a high P/E ratio suggest caution.
To see Spark’s full report on WST stock, click here.
More about West Pharmaceutical Services
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services, partnering with drug developers to ensure the safe and effective containment and delivery of medicines. With over 10,000 employees across 50 sites, including 25 manufacturing facilities, West supports its customers by delivering over 41 billion components and devices annually. Headquartered in Exton, Pennsylvania, the company generated $2.89 billion in net sales in fiscal year 2024 and is traded on the New York Stock Exchange under the symbol WST.
Average Trading Volume: 714,779
Technical Sentiment Signal: Sell
Current Market Cap: $15.15B
See more data about WST stock on TipRanks’ Stock Analysis page.